Antihypertensive medications and sexual function in women: baseline data from the SBP intervention trial (SPRINT)

Objectives: Hypertension is a risk factor for the development of cardiovascular and kidney disease, but treatment can substantially reduce risks. Many patients avoid antihypertensive medications because of fear of side-effects. Although associations between antihypertensives and sexual dysfunction in men have been documented, it remains unclear whether antihypertensives are associated with sexual dysfunction in women. We conducted a cross-sectional analysis of baseline data from women in the Systolic Blood Pressure Intervention Trial (SPRINT) to evaluate the relations among class of antihypertensive medication and the outcomes: sexual activity and sexual function. Methods: SPRINT enrolled individuals 50 and older with hypertension at high risk for cardiovascular disease. A subset of participants completed questionnaires regarding quality of life, including sexual function. Antihypertensive class was determined by medications taken at baseline. Results: Of 690 women in the quality of life subset of SPRINT, 183 (26.5%) were sexually active. There were no significant differences in sexual activity among women taking one or more antihypertensives and women not taking any. Women taking an angiotensin-converting enzyme inhibitor or angiotensin receptor blocker had higher odds of sexual activity [odds ratio 1.66 (1.12–4.27), P = 0.011]. Among sexually active women, the prevalence of sexual dysfunction was high (52.5%). No class of medication was associated with sexual dysfunction in the multivariable model. Conclusion: Angiotensin-converting enzyme inhibitor or angiotensin receptor blocker use was associated with higher odds of sexual activity. Although prevalence of sexual dysfunction was high, no single class of antihypertensive medication was associated with sexual dysfunction.

[1]  J. Williamson,et al.  The design and rationale of a multicenter clinical trial comparing two strategies for control of systolic blood pressure: The Systolic Blood Pressure Intervention Trial (SPRINT) , 2014, Clinical trials.

[2]  R. Hess,et al.  Sexual activity in midlife women: importance of sex matters. , 2014, JAMA internal medicine.

[3]  H. Krumholz,et al.  Sexual activity and function among middle-aged and older men and women with hypertension , 2013, Journal of hypertension.

[4]  M. Préville,et al.  Validation of the Female Sexual Function Index (FSFI) and presentation of norms in older women , 2012 .

[5]  R. Ma,et al.  Effect of felodipine with irbesartan or metoprolol on sexual function and oxidative stress in women with essential hypertension , 2012, Journal of hypertension.

[6]  J. Manson,et al.  Patterns and predictors of sexual activity among women in the Hormone Therapy trials of the Women's Health Initiative , 2011, Menopause.

[7]  B. Okeahialam,et al.  Impact of hypertension on sexual function in women. , 2010, West African journal of medicine.

[8]  Stacy Tessler Lindau,et al.  Sex, health, and years of sexually active life gained due to good health: evidence from two US population based cross sectional surveys of ageing , 2010, BMJ : British Medical Journal.

[9]  P. Chedraui,et al.  Assessment of sexuality among middle-aged women using the Female Sexual Function Index , 2009, Climacteric : the journal of the International Menopause Society.

[10]  A. Manolis,et al.  Sexual dysfunction: the ‘prima ballerina’ of hypertension-related quality-of-life complications , 2008, Journal of hypertension.

[11]  Wendy Levinson,et al.  A study of sexuality and health among older adults in the United States. , 2007, The New England journal of medicine.

[12]  H. Meyer-Bahlburg,et al.  The Female Sexual Function Index: A Methodological Critique and Suggestions for Improvement , 2007, Journal of sex & marital therapy.

[13]  S. Douma,et al.  Female sexual dysfunction in essential hypertension: a common problem being uncovered , 2006, Journal of hypertension.

[14]  N. Mochizuki,et al.  Angiotensin II Type 1 Receptor Blocker Prevents Atrial Structural Remodeling in Rats with Hypertension Induced by Chronic Nitric Oxide Inhibition , 2006, Hypertension Research.

[15]  E. Vittinghoff,et al.  Sexual Activity and Function in Middle-Aged and Older Women , 2006, Obstetrics and gynecology.

[16]  C. McCulloch,et al.  Elevated blood pressure and risk of end-stage renal disease in subjects without baseline kidney disease. , 2005, Archives of internal medicine.

[17]  R. Rosen,et al.  The Female Sexual Function Index (FSFI): Cross-Validation and Development of Clinical Cutoff Scores , 2005, Journal of sex & marital therapy.

[18]  I. Goldstein,et al.  Physiology of female sexual function: animal models. , 2004, The journal of sexual medicine.

[19]  L. Dobrucki,et al.  Third-Generation &bgr;-Blockers Stimulate Nitric Oxide Release From Endothelial Cells Through ATP Efflux: A Novel Mechanism for Antihypertensive Action , 2003, Circulation.

[20]  R. Fogari,et al.  Effect of valsartan and atenolol on sexual behavior in hypertensive postmenopausal women. , 2003, American journal of hypertension.

[21]  A. Genazzani,et al.  Serum Allopregnanolone Levels Relate to FSFI Score During the Menstrual Cycle , 2003, Journal of sex & marital therapy.

[22]  A. Marquand,et al.  [Sexual dysfunction in treated hypertensive patients. Results of a national survey]. , 2002, Archives des maladies du coeur et des vaisseaux.

[23]  R. Fogari,et al.  Effect of antihypertensive treatment with valsartan or atenolol on sexual activity and plasma testosterone in hypertensive men , 2002, European Journal of Clinical Pharmacology.

[24]  H. Burger,et al.  Female androgen insufficiency: the Princeton consensus statement on definition, classification, and assessment. , 2002, Fertility and sterility.

[25]  A. Guay,et al.  Decreased Free Testosterone and Dehydroepiandrosterone-sulfate (DHEA-S) Levels in Women with Decreased Libido , 2002, Journal of sex & marital therapy.

[26]  L. Ghiadoni,et al.  Effect of calcium antagonist or beta blockade treatment on nitric oxide-dependent vasodilation and oxidative stress in essential hypertensive patients , 2001, Journal of hypertension.

[27]  J. Coresh,et al.  Prevalence of high blood pressure and elevated serum creatinine level in the United States: findings from the third National Health and Nutrition Examination Survey (1988-1994). , 2001, Archives of internal medicine.

[28]  H. Drexler,et al.  Comparative Effect of ACE Inhibition and Angiotensin II Type 1 Receptor Antagonism on Bioavailability of Nitric Oxide in Patients With Coronary Artery Disease: Role of Superoxide Dismutase , 2001, Circulation.

[29]  A. Riley.  Controlled Studies on Women Presenting with Sexual Drive Disorder: I. Endocrine Status , 2000, Journal of sex & marital therapy.

[30]  T. Pearson,et al.  Does hypertension and its pharmacotherapy affect the quality of sexual function in women? , 2000, American journal of hypertension.

[31]  S. Kurowski,et al.  Sildenafil relaxes rabbit clitoral corpus cavernosum. , 2000, Life sciences.

[32]  E. Perez-stable,et al.  The effects of propranolol on cognitive function and quality of life: a randomized trial among patients with diastolic hypertension. , 2000, The American journal of medicine.

[33]  Candace S. Brown,et al.  The Female Sexual Function Index (FSFI): A Multidimensional Self-Report Instrument for the Assessment of Female Sexual Function , 2000, Journal of sex & marital therapy.

[34]  A. Araujo,et al.  Incidence of erectile dysfunction in men 40 to 69 years old: longitudinal results from the Massachusetts male aging study. , 2000, The Journal of urology.

[35]  S. Dhein,et al.  Amlodipine releases nitric oxide from canine coronary microvessels: An unexpected mechanism of action of a calcium channel-blocking agent. , 1999, Circulation.

[36]  S. Moncada,et al.  Nitrergic neurotransmission mediates the non‐adrenergic non‐cholinergic responses in the clitoral corpus cavernosum of the rabbit , 1998, British journal of pharmacology.

[37]  I. Holme,et al.  Effects of doxazosin and atenolol on atherothrombogenic risk profile in hypertensive middle-aged men. , 1998, Journal of cardiovascular pharmacology.

[38]  E. Giltay,et al.  Chronic renal failure and sexual functioning: clinical status versus objectively assessed sexual response. , 1997, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[39]  Jan A Staessen,et al.  Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension , 1997, The Lancet.

[40]  X. Xu,et al.  ACE inhibitors promote nitric oxide accumulation to modulate myocardial oxygen consumption. , 1997, Circulation.

[41]  J. Bancroft,et al.  Steroid hormones, the menopause, sexuality and well-being of women , 1996, Psychological Medicine.

[42]  P. Wilson,et al.  Established risk factors and coronary artery disease: the Framingham Study. , 1994, American journal of hypertension.

[43]  L. Passman,et al.  The treatment of mild hypertension study. , 1993, JAMA.

[44]  T. Mulligan,et al.  Effect of Frequently Prescribed Cardiovascular Medications on Sexual Function: A Pilot Study , 1993, The Annals of pharmacotherapy.

[45]  J. Cutler,et al.  Treatment of Mild Hypertension Study. Final results. Treatment of Mild Hypertension Study Research Group. , 1993, JAMA.

[46]  C. Lewis,et al.  Treatment of Mild Hypertension Study: Final Results , 1993 .

[47]  M. Chesney,et al.  The impact of diuretic therapy on reported sexual function. , 1991, Archives of internal medicine.

[48]  M. Blaufox,et al.  Effect of antihypertensives on sexual function and quality of life: the TAIM Study. , 1991, Annals of internal medicine.

[49]  John Bancroft,et al.  Testosterone and sexual behavior in oral contraceptive users and nonusers: A prospective study , 1990, Hormones and Behavior.

[50]  T. Saruta,et al.  Effects of first‐line antihypertensive agents on sexual function and sex hormones , 1988, Journal of hypertension. Supplement : official journal of the International Society of Hypertension.

[51]  J. Clive,et al.  Sexual symptoms in hypertensive patients. A clinical trial of antihypertensive medications. , 1988, Archives of internal medicine.

[52]  B. Sherwin,et al.  The role of androgen in the maintenance of sexual functioning in oophorectomized women. , 1987, Psychosomatic medicine.

[53]  G. Klerman,et al.  The effects of antihypertensive therapy on the quality of life. , 1986, The New England journal of medicine.

[54]  E. Nelson,et al.  Identification of the noncompliant hypertensive patient. , 1980, Preventive medicine.

[55]  Tsyvkin Mv,et al.  LEADING CAUSES OF DEATH. , 1964, WHO chronicle.

[56]  M. Ruzicka,et al.  A Randomized Trial of Intensive versus Standard Blood-Pressure Control. , 2017, The New England journal of medicine.

[57]  M. Smits,et al.  A Randomized Trial of Intensive versus Standard Blood-Pressure Control. , 2016, The New England journal of medicine.

[58]  E. Laumann,et al.  Sexual problems among women and men aged 40–80 y: prevalence and correlates identified in the Global Study of Sexual Attitudes and Behaviors , 2005, International Journal of Impotence Research.

[59]  E. O’Brien,et al.  Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The Systolic Hypertension in Europe (Syst-Eur) Trial Investigators. , 1997, Lancet.

[60]  C. Lewis,et al.  Long-term effects on sexual function of five antihypertensive drugs and nutritional hygienic treatment in hypertensive men and women. Treatment of Mild Hypertension Study (TOMHS) , 1997, Hypertension.

[61]  T. Ogihara,et al.  Effect of manidipine, a novel calcium channel blocker, on quality of life in hypertensive patients. , 1992, Blood pressure. Supplement.

[62]  W. de Oliveira Júnior.  [The effects of antihypertensive therapy on the quality of life]. , 1989, Arquivos brasileiros de cardiologia.

[63]  C. Bulpitt,et al.  Angiotensin converting enzyme inhibitors and quality of life: the European trial. , 1985, Journal of hypertension. Supplement : official journal of the International Society of Hypertension.

[64]  A randomized trial of propranolol in patients with acute myocardial infarction. I. Mortality results. , 1982, JAMA.